EGPAF to share prevention of mother-to-child-transmission of HIV lessons and challenges


In an upcoming webinar, Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) staff and partners will discuss current trends in mother-to-child HIV transmission and prevention access.

With optimal access to antiretroviral formulations, a pregnant HIV-positive woman has a very minimal risk of transmitting HIV to her infant through pregnancy, delivery, or breastfeeding. HIV infection rates remain high in some countries, particularly among women of reproductive age, and access to ARVs is not a guarantee. ARV access to prevent vertical transmission is further strained in some settings due to social distancing guidelines in place for COVID-19.

We'll discuss gains made, and gains lost over the last year. We'll also address novel strategies and innovations that could turn the tide on a worrying trend. The agenda includes voices from across the field: leaders, experts, field-based staff, and a beneficiary of prevention of mother-to-child HIV transmission services.


Opening remarks: Chip Lyons, EGPAF President and CEO

Following the data/latest MTCT research: Dorothy Mbori-Ngacha, UNICEF HIV Specialist

The MTCT plateau in DRC: Dr. Vicky Ilunja, EGPAF Technical Director, DRC

Global innovations strengthening PMTCT: Dr. Lynne Mofenson, EGPAF Sr Research Advisor

Learnings from Eswatini around MTCT success, Dr. Christopher Makwindi

The PMTCT journey, a client experience: Dee Mphafi, EGPAF-Lesotho Youth Advisor


Register to attend the webinar here.

For more on the Elisabeth Glaser Pediatric AIDS Foundation, click here.

© 2024 MJH Life Sciences

All rights reserved.